FDA Grants Full Approval to Blinatumomab for Acute Lymphoblastic Leukemia

News   Jul 27, 2017 | Original story from NIH

 
FDA Grants Full Approval to Blinatumomab for Acute Lymphoblastic Leukemia

Credit: Christaras A, CC BY 2.5

 
 
 

RELATED ARTICLES

Discovery of Immune Defense Mechanism Could Help Improve Treatments

News

Researchers have identified a previously unknown mechanism by which the responses of key cells of the immune system are regulated. The finding could inform research into improved treatments for allergies or chronic inflammatory diseases.

READ MORE

Computer Program Helps Find Ways to Repurpose Existing Drugs

News

Researchers have developed a computer program to find new indications for old drugs. The computer program, called DrugPredict, matches existing data about FDA-approved drugs to diseases, and predicts potential drug efficacy.

READ MORE

AIDS Vaccine: Developing a New Strategy

News

The type of vaccine administered and the activation of the body's own immune cells influence the vaccine protection.

READ MORE

 

Comments | 0 ADD COMMENT

Like what you just read? You can find similar content on the communities below.

Biopharma

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE